+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Synthetic Biology Market - Global Outlook and Forecast 2022-2027

  • PDF Icon

    Report

  • 378 Pages
  • July 2022
  • Region: Global
  • Arizton
  • ID: 5639207
UP TO OFF until Sep 30th 2022
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global synthetic biology market is expected to grow at a CAGR of 25% during 2022-2027.

Synthetic biology is a new interdisciplinary field that includes the application of engineering principles to biology. It intends to design and manufacture biological components and systems that do not yet exist in nature. Synthetic biology combines the chemical synthesis of DNA with increased knowledge of genetics to enable researchers to quickly create cataloged DNA sequences and assemble them into new genomes. With the improved speed and cost of DNA synthesis, scientists can use advanced biofuels, bioproducts, renewable chemicals, bio-based specialty chemicals, pharmaceutical intermediates, fine chemicals, and food ingredients.

Industrial biotechnology provides tools to improve the natural mechanisms of biological processes for the efficient production of enzymes, chemicals, polymers, and even daily necessities such as foods and fuels. Scientists have studied the genomes of microorganisms to identify biological processes that can replace chemical reactions, create new products, make manufacturing processes cleaner, and reduce the number of manufacturing steps. Industrial biotechnology innovations are now successfully competing and replacing traditional petrochemical manufacturing processes. Companies using synthetic biology believe that they can reduce costs, reduce pollution and carbon dioxide emissions, and increase profitability.

The various approaches that synthetic biology encompasses, such as the design of gene and protein circuits from standard biological parts, the development of synthetic genetic codes, and the creation of artificial cells and organisms, will undoubtedly allow for the application of knowledge in different branches of science and technology. Redesigning the existing biological parts expands the set of functions for biological processes. Synthetic biology can allow new perspectives and the creation of new biological innovations. Development of technology platforms or creating new or upgraded physical structures can be used to implement new functions and reap benefits.

The following factors will drive the global synthetic biology market growth:

  • Synthetic Biology Market Witnessing Significant Rise in Investments
  • Increasing Strategic Collaborations & Acquisitions. Developing Multifunctional Products
  • Synthetic Biology Bringing Transformative Technologies to Agriculture

Synthetic biology brings a paradigm shift in the field of biomedicine


Synthetic Biology offers modern approaches for engineering new biological systems or redesigning existing ones for practical purposes. CAR-T therapy has some crucial advantages that may not be available with other drugs used for cancer treatment.

The synthetic biology market is witnessing a significant rise in investments.

There is a massive inflow of investments for synthetic biology start-ups as they provide innovative market solutions. There are various pipeline products for the same. Some markets like Germany, China, and Italy are progressing toward a mature markets. In contrast, some regions like Africa do not have a significant number of companies or academic institutes for the same. In contrast, countries like India are in the nascent stages of synthetic biology. There are more opportunities in synthetic biology than challenges in the current scenario. Still, some ethical issues need to be addressed.

Synthetic biology products are transforming the world.

Synthetic biology has the potential to develop real-world applications. Synthetic biology can transform food, source materials, and medicines. Many biotechnologies, pharmaceutical, and agriculture companies best highlight applying synthetic biology tools developed from 2000-to 2021 and are available now or in the coming years. Over the next decade, more products will derive superior performance and affordability from engineering biology. The field is already impacting life sciences & pharmaceuticals, and industrial applications on a large scale.

GEOGRAPHY INSIGHTS


North America: Factors driving the market's growth in the region include a wide range of synthetic biology applications, the rising R&D funding and growing initiatives in synthetic biology, the declining costs of genome sequencing and synthesis, and the increasing investments in the market. The synthetic biology market is growing and rapidly accelerating into industrial, food & agriculture, and environmental areas. The region also has highly advanced genomic labs and genomic research centers involved in conducting large-scale research projects per the market demand. They are collaborating with pharma and biotech companies across the world. In North America, a larger population is involved in agriculture practice. More than 3.2 million hectares of land are used for organic farming alone. This region has one of the largest genetically modified (GM) crops approved, which can be grown to fulfill the demand in the market.

Europe: This region shows multiple research projects conducted in various European countries in Life Science segments. Europe stands second after the North American area in the genome sequencing field of cell and gene therapy. These fields demand extensive research and development infrastructure to handle complex analyses like sequencing millions of base pairs and analyzing complex data. The market players in this region are focusing on investment in R&D with notables competition among the prominent and emerging players.

APAC: The stringent regulatory requirements, and high cost of maintenance of the technology infrastructure, hamper the market's growth in the APAC region. The government support in most Asian countries accelerates the development of biopharmaceuticals in the region. Moreover, biosimilars manufacturing is expanding in developing countries, owing to affordability in production as it requires low per capita spending. Vaccine manufacturing is one segment that has primarily adopted the usage of synthetic biology in them for net yield and to reduce the cost of manufacturing in the market. In addition to this, it was observed in the agri-food sector with five Asian countries in the top 10 investment markets for agri-food receiving a considerable amount compared to the US the global funding.

Latin America: Latin America is home to many developing and underdeveloped countries. The usage of advanced biotechnology-related products like synthetic biology in the industries is moderate, as there is a lack of stringent regulatory requirements in manufacturing the products. The Latin American countries still lack developed infrastructure in various life sciences segments. Latin America will be a significant food processing market with an increased number of research labs and processing industries working. Latin American countries are elaborating the policy framework for developing the economy, which is underway in several countries. They also focus on building sustainable environmental conditions using synthetic biology tools in the market. Latin America is a major exporter of food & agricultural commodities, accounting for more than 16% of the global food & agriculture exports and 4% of the total food & agriculture imports.

Middle East & Africa: The opportunity for synthetic biology products like GM crops that can grow in extreme conditions and yield better are some options that synthetic biology can provide to some African countries. African countries face malnutrition, diseases, hunger, and pollution challenges, which can only be solved using synthetic biology products. Positive factors towards the adoption of synthetic biology are various foundations coming up in the country, Synbio Africa, which are tasked to harmonize the efforts of scientists, students, researchers, farmers, and policymakers to impact communities in Africa positively. The scenario in the middle east countries is different. Various advancements related to environmentally friendly products reduce pollution, as many refineries exist in the country. Exploring new products for research are also being performed in the middle east countries.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia

SEGMENTATION ANALYSIS


Tools Insights


Synthetic biology products are (re-)designed products of existing life forms or the creation of new life forms. Synthetic biology differs from traditional molecular and cellular biology because it focuses on developing and constructing tools that can be modeled, understood, and optimized to meet specific performance criteria. These smaller parts and devices are assembled into larger integrated systems to solve problems or yield better outcomes. The synthetic DNA market generated a significant chunk of revenue during the forecast period. Synthetic DNA is growing as an alternative to device-based technology in data storage, product labeling, and signal processing.

The enzymes market will grow at a CAGR of ~26% during the forecast period. Microbial-derived enzymes have great potential for waste management and, by extension, the development of an environment-friendly environment. Enzymes are effectively used in many industries for higher quality production with harmless environmental pollution and accelerated reaction rates with cost-efficiency.

Technology Insights


The synthetic biology applications require continued development of enabling & enabled technologies to ensure these technologies remain accessible for research. The enabling technologies are emerging rapidly and being applied in various healthcare, industrial, food & agricultural, and large-scale environmental projects. The applications of enabling technologies in synthetic biology are widely accepted.

Applications Insights


Synthetic biology offers a wide range of applications in biomedicine, therapeutics, diagnostics, and advanced therapies. The food & agriculture sector is also implementing genome-based research for new viable product development to overcome the modern solutions in modern days. By transforming biology by creating and developing bio-based therapies, chemicals, materials, fresh food, and energy sources, synthetic biology tools, technology, and engineering principles improve and protect the natural environment. General synthetic biology is applied in a wide range of fields, and it impacts the betterment of lives.

End-user Insights


The end-users widely accept the use and research scope of synthetic biology. Academic/research institutes & laboratories are the first point of research studies on synthetic biology tools and techniques. The research provides a deep understanding of tools and technologies for the potential impact of synthetic biology products in a particular segment or sector. The emergence and advancements in synthetic biology have significantly impacted the healthcare industry. Pharma & biotech companies are the platform for research investments and commercializing products in the market. The major players in the market raise funds for research and collaborate/acquire other institutes.

Segmentation by Tools

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technology Kits
  • Xeno-Nucleic Acids
  • Chassis Organisms

Segmentation by Technology

  • Enabling Technology
  • Enabled Technology

Segmentation by Application

  • Healthcare Application
  • Industrial Application
  • Food & Agriculture Applications
  • Environmental Application

Segmentation by End-user

  • Academic/Research Institutes & Laboratories
  • Pharma & Biotech Companies
  • Others

Key Vendors

  • Agilent Technologies
  • Codexis
  • Eurofins Scientific
  • Illumina
  • Novozymes
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Amyris
  • ATUM
  • Bio-Rad Laboratories
  • Creative Biogene
  • Creative Enzymes
  • Cyrus Biotechnology
  • Editas Medicine
  • Genomatica
  • Genscript
  • Ginkgo Bioworks
  • Integrated DNA Technologies
  • Lucigen
  • Moderna
  • New England Biolabs
  • OriGene Technologies
  • Precigen
  • Sentebiolab
  • SynbiCITE
  • Synthego
  • Tessera Therapeutics
  • Viridos

KEY QUESTIONS ANSWERED


1. WHAT IS THE MARKET VALUE OF THE GLOBAL SYNTHETIC BIOLOGY MARKET?
2. WHAT IS THE ESTIMATED GROWTH RATE OF THE GLOBAL SYNTHETIC BIOLOGY MARKET?
3. WHICH REGION HOLDS THE LARGEST SHARE IN THE GLOBAL SYNTHETIC BIOLOGY MARKET?
4. WHO ARE THE KEY PLAYERS IN THE GLOBAL SYNTHETIC BIOLOGY MARKET?
5. WHAT ARE THE GROWTH FACTORS DRIVING THE GLOBAL SYNTHETIC BIOLOGY MARKET?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Tools
4.3.2 Market Segmentation by Technology
4.3.3 Market Segmentation by Applications
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 History of Synthetic Biology
7.1.2 Synthetic Biology
8 Market Opportunities & Trends
8.1 Real-World Applications of Synthetic Biology Products
8.2 Synthetic Biology in Biomedicine
8.3 Synthetic Dna as a New Storage Device
9 Market Growth Enablers
9.1 Rise in Market Investments
9.2 Strategic Collaborations & Acquisitions to Develop Multifunctional Products
9.3 Transformative Synthetic Biology Technologies in Agriculture
10 Market Restraints
10.1 Misuse of Synthetic Biology
10.2 Synthetic Biology-Induced Changes in Global Biosecurity Framework
10.3 Threat to Existing Technologies
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geography Insights
11.2.2 Tools Insights
11.2.3 Technology Insights
11.2.4 Applications Insights
11.2.5 End-User Insights
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Tools
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Oligonucleotides & Synthetic Dna
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Oligonucleotides & Synthetic Dna Segmentation by Geography
12.4 Enzymes
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Enzymes Segmentation by Geography
12.5 Cloning Technology Kits
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Cloning Technology Kits Segmentation by Geography
12.6 Xeno-Nucleic Acids
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.6.3 Xeno-Nucleic Acids Segmentation by Geography
12.7 Chassis Organisms
12.7.1 Market Overview
12.7.2 Market Size & Forecast
12.7.3 Chassis Organisms Segmentation by Geography
13 Technology
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Enabling Technology
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Enabling Technology Segmentation by Geography
13.4 Enabled Technology
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Enabled Technology Segmentation by Geography
14 Applications
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Healthcare Applications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Healthcare Applications Segmentation by Geography
14.4 Industrial Applications
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Industrial Applications Segmentation by Geography
14.5 Food & Agriculture Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Food & Agriculture Applications Segmentation by Geography
14.6 Environmental Applications
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Environmental Applications Segmentation by Geography
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Academic/Research Institutes & Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Academic/Research Institutes & Laboratories Segmentation by Geography
15.4 Pharma & Biotech Companies
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Pharma & Biotech Companies Segmentation by Geography
15.5 Others
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Others Segmentation by Geography
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 North America by Tools Segmentation
17.2.2 North America by Technology Segmentation
17.2.3 North America by Applications Segmentation
17.2.4 North America by End-User Segmentation
17.3 Key Countries
17.3.1 Us: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Europe by Tools Segmentation
18.2.2 Europe by Technology Segmentation
18.2.3 Europe by Applications Segmentation
18.2.4 Europe by End-User Segmentation
18.3 Key Countries
18.3.1 Uk: Market Size & Forecast
18.3.2 Germany: Market Size & Forecast
18.3.3 France: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 Apac
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 APAC by Tools Segmentation
19.2.2 APAC by Technology Segmentation
19.2.3 APAC by Applications Segmentation
19.2.4 APAC by End-User Segmentation
19.3 Key Countries
19.3.1 Japan: Market Size & Forecast
19.3.2 China: Market Size & Forecast
19.3.3 South Korea: Market Size & Forecast
19.3.4 Australia: Market Size & Forecast
19.3.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Latin America by Tools Segmentation
20.2.2 Latin America by Technology Segmentation
20.2.3 Latin America by Applications Segmentation
20.2.4 Latin America by End-User Segmentation
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Middle East & Africa by Tools Segmentation
21.2.2 Middle East & Africa by Technology Segmentation
21.2.3 Middle East & Africa by Applications Segmentation
21.2.4 Middle East & Africa by End-User Segmentation
21.3 Key Countries
21.3.1 Turkey: Market Size & Forecast
21.3.2 South Africa: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Agilent Technologies
22.2.2 Codexis
22.2.3 Eurofins Scientific
22.2.4 Illumina
22.2.5 Novozymes
22.2.6 Thermo Fisher Scientific
23 Key Company Profiles
23.1 Agilent Technologies
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Codexis
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Eurofins Scientific
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Illumina
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Novozymes
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Thermo Fisher Scientific
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
24 Other Prominent Vendors
24.1 Amyris
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Atum
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Bio-Rad Laboratories
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Creative Biogene
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Creative Enzymes
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Cyrus Biotechnology
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Editas Medicine
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Genomatica
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Genscript
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Ginkgo Bioworks
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Integrated Dna Technologies
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Lucigen
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 New England Biolabs
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Origene Technologies
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Precigen
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Sentebiolab
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 Synbicite
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Synthego
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 Tessera Therapeutics
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Viridos
24.20.1 Business Overview
24.20.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Tools
26.1.1 North America by Tools Segmentation
26.1.2 Europe by Tools Segmentation
26.1.3 APAC by Tools Segmentation
26.1.4 Latin America by Tools Segmentation
26.1.5 Middle East & Africa by Tools Segmentation
26.2 Technology
26.2.1 North America by Technology Segmentation
26.2.2 Europe by Technology Segmentation
26.2.3 APAC by Technology Segmentation
26.2.4 Latin America by Technology Segmentation
26.2.5 Middle East & Africa by Technology Segmentation
26.3 Applications
26.3.1 North America by Applications Segmentation
26.3.2 Europe by Applications Segmentation
26.3.3 APAC by Applications Segmentation
26.3.4 Latin America by Applications Segmentation
26.3.5 Middle East & Africa by Applications Segmentation
26.4 End-User
26.4.1 North America by End-User Segmentation
26.4.2 Europe by End-User Segmentation
26.4.3 APAC by End-User Segmentation
26.4.4 Latin America by End-User Segmentation
26.4.5 Middle East & Africa by End-User Segmentation
26.5 Geography
26.5.1 Oligonucleotides & Synthetic Dna Segmentation by Geography
26.5.2 Enzymes Segmentation by Geography
26.5.3 Cloning Technology Kits Segmentation by Geography
26.5.4 Xeno-Nucleic Acids Segmentation by Geography
26.5.5 Chassis Organisms Segmentation by Geography
26.5.6 Enabling Technology Segmentation by Geography
26.5.7 Enabled Technology Segmentation by Geography
26.5.8 Healthcare Applications Segmentation by Geography
26.5.9 Industrial Applications Segmentation by Geography
26.5.10 Food & Agriculture Applications Segmentation by Geography
26.5.11 Environmental Applications Segmentation by Geography
26.5.12 Academic/Research Institutes & Laboratories Segmentation by Geography
26.5.13 Pharma & Biotech Companies Segmentation by Geography
26.5.14 Others Segmentation by Geography
27 Appendix
27.1 Abbreviations

Companies Mentioned

  • Agilent Technologies
  • Codexis
  • Eurofins Scientific
  • Illumina
  • Novozymes
  • Thermo Fisher Scientific
  • Amyris
  • ATUM
  • Bio-Rad Laboratories
  • Creative Biogene
  • Creative Enzymes
  • Cyrus Biotechnology
  • Editas Medicine
  • Genomatica
  • Genscript
  • Ginkgo Bioworks
  • Integrated DNA Technologies
  • Lucigen
  • Moderna
  • New England Biolabs
  • OriGene Technologies
  • Precigen
  • Sentebiolab
  • SynbiCITE
  • Synthego
  • Tessera Therapeutics
  • Viridos

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...